Hospital
Union General Hospital INC
Union General Hospital INC was paid $6.32M by Medicaid between Jan 2018 and Dec 2024, across 163 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.
33Billing provider infoUNION GENERAL HOSPITAL INC
BLAIRSVILLE, GA 30512
BLAIRSVILLE, GA 30512
33aNPI1235408253assigned 12/20/2011
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.32M
24GClaims233,825
24DCodes billed163
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Georgia
Rank by total paid#6 of 34
Median peer was paid$23K
This provider vs. median274×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 37,498 | $1.24M | |
| 2019 | 33,200 | $860K | |
| 2020 | 23,840 | $626K | |
| 2021 | 30,530 | $757K | |
| 2022 | 41,174 | $927K | |
| 2023 | 42,146 | $988K | |
| 2024incomplete | 25,437 | $917K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 9,035 | 7,826 | $1.98M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 9,564 | 8,638 | $1.56M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.0% | 4,629 | 3,935 | $568K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.4% | 2,079 | 1,919 | $217K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.9% | 5,773 | 3,372 | $181K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.7% | 1,662 | 1,498 | $171K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 2,207 | 1,976 | $113K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.8% | 1,191 | 1,056 | $112K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 4,895 | 3,752 | $97K |
| G0378 | Hospital observation service, per hour | 1.4% | 1,095 | 762 | $90K |
| 80053 | Comprehensive metabolic panel | 1.1% | 14,963 | 11,136 | $67K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 878 | 813 | $55K |
151 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,653 | $50K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,016 | $50K |
| 97597 | <1% | 804 | $50K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,357 | $48K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,091 | $47K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,149 | $46K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,365 | $39K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,109 | $33K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,361 | $32K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,955 | $31K |
| 84484 | <1% | 4,631 | $31K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,155 | $30K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,646 | $28K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,261 | $27K |
| 83880 | <1% | 1,712 | $27K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,760 | $26K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 731 | $24K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,996 | $22K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,205 | $22K |
| 83735 | <1% | 7,849 | $20K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,596 | $18K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 530 | $17K |
| 87040 | <1% | 2,748 | $14K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,166 | $14K |
| 83605 | <1% | 2,993 | $14K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,459 | $13K |
| 73564 | <1% | 349 | $13K | |
| J3490 | Unclassified drugs | <1% | 188 | $13K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,256 | $12K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 405 | $11K |
| 87070 | <1% | 3,326 | $11K | |
| 81000 | <1% | 7,966 | $11K | |
| 71250 | <1% | 84 | $10K | |
| 83690 | <1% | 3,307 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,867 | $10K |
| 97161 | <1% | 366 | $9K | |
| 87186 | <1% | 2,060 | $9K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 384 | $9K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,916 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,347 | $8K |
| 96376 | <1% | 1,435 | $8K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,018 | $8K |
| 93325 | <1% | 313 | $7K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 3,147 | $7K |
| 73630 | <1% | 154 | $7K | |
| 86140 | <1% | 3,433 | $7K | |
| 80061 | Lipid panel | <1% | 1,121 | $7K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 254 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,600 | $6K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 66 | $6K |
| 85027 | <1% | 1,711 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 247 | $5K |
| 82803 | <1% | 459 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 213 | $4K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 699 | $4K |
| 73030 | <1% | 182 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 91 | $4K |
| 85610 | <1% | 2,119 | $4K | |
| 82150 | <1% | 1,405 | $4K | |
| 81025 | <1% | 1,251 | $4K | |
| 85730 | <1% | 1,501 | $4K | |
| 93304 | <1% | 70 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 730 | $4K |
| 73610 | <1% | 102 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 168 | $3K |
| 85007 | <1% | 1,728 | $3K | |
| 87077 | <1% | 518 | $3K | |
| 93321 | <1% | 145 | $2K | |
| 87088 | <1% | 707 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 24 | $2K |
| 81001 | <1% | 1,367 | $2K | |
| 82962 | <1% | 2,140 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,855 | $2K |
| 84703 | <1% | 1,109 | $2K | |
| 82077 | <1% | 244 | $2K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 13 | $2K |
| 94060 | <1% | 19 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,509 | $2K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 37 | $2K |
| 87280 | <1% | 818 | $1K | |
| 97602 | <1% | 87 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 87 | $1K |
| 76801 | <1% | 16 | $1K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 17 | $1K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 580 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,283 | $1K |
| 84702 | <1% | 211 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,984 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 683 | $1K |
| 80143 | <1% | 136 | $1K | |
| 80179 | <1% | 136 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 621 | $965.40 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,229 | $845.01 |
| 73560 | <1% | 27 | $712.70 | |
| 85379 | <1% | 141 | $660.85 | |
| 84439 | <1% | 122 | $650.83 | |
| 96367 | <1% | 160 | $648.72 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 119 | $647.66 |
| 88304 | <1% | 27 | $589.78 | |
| 81003 | <1% | 593 | $587.40 | |
| 80358 | <1% | 35 | $466.83 | |
| 83992 | <1% | 35 | $446.46 | |
| 93000 | <1% | 14 | $421.54 | |
| 73110 | <1% | 12 | $395.30 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 185 | $390.83 |
| 73502 | <1% | 20 | $350.84 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $348.41 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 293 | $337.21 |
| 85651 | <1% | 193 | $314.58 | |
| 80346 | <1% | 21 | $303.37 | |
| 80324 | <1% | 21 | $292.24 | |
| 80361 | <1% | 21 | $288.68 | |
| 87205 | <1% | 179 | $259.32 | |
| 74018 | <1% | 15 | $249.08 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 124 | $227.75 |
| 80345 | <1% | 21 | $227.08 | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | <1% | 89 | $226.08 |
| 80320 | <1% | 31 | $220.09 | |
| 36600 | <1% | 32 | $217.35 | |
| 94762 | <1% | 14 | $215.44 | |
| 80353 | <1% | 21 | $195.21 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 72 | $173.23 |
| 86901 | <1% | 76 | $140.40 | |
| 81015 | <1% | 403 | $126.37 | |
| 86900 | <1% | 78 | $116.89 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 372 | $103.55 |
| 82565 | <1% | 29 | $101.83 | |
| 80050 | General health panel | <1% | 990 | $98.18 |
| 82728 | <1% | 25 | $94.78 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 53 | $65.35 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 103 | $63.03 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 390 | $59.54 |
| 36416 | <1% | 255 | $57.40 | |
| 82607 | <1% | 13 | $55.73 | |
| 82550 | <1% | 44 | $45.62 | |
| 84100 | <1% | 69 | $43.13 | |
| 80349 | <1% | 20 | $31.18 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 354 | $27.89 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 15 | $24.93 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 28 | $13.27 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 18 | $6.56 |
| A4217 | Sterile water/saline, 500 ml | <1% | 12 | $5.57 |
| S0028 | Injection, famotidine, 20 mg | <1% | 29 | $3.78 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 19 | $3.71 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 15 | $1.41 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 368 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 39 | $0.00 |
| A9270 | Non-covered item or service | 0% | 5,406 | $0.00 |
| 1036F | 0% | 28 | $0.00 | |
| 3008F | 0% | 28 | $0.00 | |
| 3074F | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTOWNSEND, NICHOLAS (CHIEF FINANCIAL OFFICER)
Parent organizationUNION COUNTY HOSPITAL AUTHORITY
| Provider | Location | Paid |
|---|---|---|
| Union County Hospital Authority | Blairsville, GA | $71K |
| Union County Hospital Authority | Blairsville, GA | $1K |
| North Carolina Affiliated Services, LLC | Hayesville, NC | $226.34 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.